Hometown coverage hits different 🏙️ FastWave is raising the bar with rupture-resistant #IVL balloons, faster & easier tech, and nearly $50M raised since 2021. Investors & docs are paying attention. Thanks Minneapolis/St.Paul Business Journal for this feature! 🔗bizj.us/1qnqp9

1/5 Innovative tech alone won’t lead to sticky adoption. Sustainable traction comes from solving real problems without creating new ones. In his latest MassDevice op-ed, @ScottNelsonLive highlights how top #medtech startup CEOs launch their devices. 👇

1/6 🧠 From FDA reviewer to #medtech CEO: Shreya’s journey with Zenflow is advancing a unique treatment for enlarged prostates – a gentle, flexible implant that's completely reversible. 👇

🔥 FastWave made the FierceBiotech #Fierce15! Why Conor Hale thinks we’re fierce: ⚡ Dual IVL platforms for different anatomies 🧠 Simple usability with hands-free therapy delivery 💥 Faster energy, more pulses, and broader pressure output 🔗shorturl.at/L1xi0

⚡️ Sola™ has officially entered the chat. First-in-human procedures complete in our feasibility study of this next-gen #coronary laser IVL system (L-IVL) — delivering 5Hz, 360° sonic pulses to tackle tough calcium. Next stop: U.S. pivotal trial. 📰 shorturl.at/bxSwD

1/6 🩺 What happens when a health system doesn’t just adopt your tech — but also invests in it and helps you scale? That’s exactly what InfoBionic.Ai pulled off with Mayo Clinic — a game-changing partnership that blends clinical use, funding, and distribution.👇

1/6 🎯 Most #medtech companies obsess over clinical data but miss what really drives adoption. Todd Usen, CEO of Adagio Medical with 30+ years in medtech, shares hard-won lessons on successful launches vs expensive failures. 🧵👇

“One of the most difficult conditions to treat.” -Amir Kaki, MD That’s calcified arterial disease — and exactly why FastWave was built. Thanks SF Weekly for spotlighting our mission. From MN to CA, we’re moving fast. 🔗 sfweekly.com/marketplace/th…

These numbers tell our story: ⚡ 2 #IVL platforms (electric + laser) ⚡ 2 first-in-human studies (peripheral + coronary) ⚡ 7 patents ⚡ $40M+ raised ⚡ $10B+ market VC Post featured FastWave's sprint to expand access to next-gen IVL. 🔗 shorturl.at/B7gfR

1/7 🧠 In high-stakes #medtech, adoption hinges on trust. Jim Corbett, CEO of AVITA Medical, has led 6 companies — public and private — and knows how to align evidence, execution, and capital. His commercialization playbook is packed with lessons for founders.👇

A lot of people have asked me if I will get involved in the NYC mayor race by supporting a candidate that can defeat Zohran Mamdani. TBH, I’m torn and undecided. Like every other city run by democrats, NYC is a broken kleptocracy. Taxes are astronomical and services are pathetic

1/2 Thinking about the best M&A play for your #medtech startup? Strategics won’t connect the dots — you need to do that for them. Ask Anthony Fernando, CEO of Asensus Surgical. His team mapped out exactly how their tech fit KARL STORZ’s strategy, long before the talks.👇🏼

1/7 🔬 Mary Lou Jepsen, PhD, founder of Openwater, is challenging every assumption about medical device development. Her radical approach: build #medicaldevices that function more like smartphones than traditional #medtech.

1/5 ✅ Getting FDA clearance is hard. Getting doctors to actually use your product? That's where a lot of medtech startups fail. Maulik Nanavaty cracked both at @Anumanainc by doing the opposite of what everyone expects. Here's how: 👇

1/8 🧠 Platform companies with endless opportunities face a cruel paradox: the more markets you could serve, the harder it becomes to succeed in any of them. Greg Lipschitz at Firefly Neuroscience Firefly Neuroscience cracked this code. Here's how: 👇

1/7 🩺 What’s stronger than physician feedback? Physician investment. Joanna Nathan, CEO of Prana Surgical, knew her lung cancer platform was real when thoracic surgeons asked to write checks. Here’s how she validated the idea — and built a smart capital strategy around it: 👇

1/8 🎯 The most valuable skill for #medtech entrepreneurs? Seeing what doesn't exist yet — and making others believe in it, too. Chris Haig + Efemoral team took bioresorbable scaffold tech that struggled commercially in coronary and found its perfect home in #PAD. Here's how: 👇

1/5 🧵 In Formula One, "slow is smooth and smooth is fast." @elmouelhii has built his medtech career on the same principle. As CEO of #TRiCares, he’s leading the first purpose-built transcatheter tricuspid valve replacement system — refined through more than a dozen iterations.

1/5 🧵 Medtech success isn’t about clever science. Tulavi CEO Josh Vose — physician, engineer, entrepreneur — has learned the hard way: clarity beats complexity every time. 👇

1/5 🧵”Consumer-first" sounds sexy — but in medtech, if not done right, it rarely lasts. Wellysis CEO Young Juhn took the opposite path: start medical, earn trust, and then think consumer. His journey shows why credibility will often beat speed. 👇🏽